Earnings Ahead

AKYA - Akoya Biosciences

6.64 -0.13 -1.92

Akoya Biosciences

Akoya Biosciences

About

Profile


Headquarters


Intraday

High
-
Low
-

52-week

High
-
Low
-

AKYA



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Akoya Biosciences GAAP EPS of -$0.22 beats by $0.06, revenue of $26.5M beats by $0.39M
  • Akoya Biosciences jumps on Q4/2023 outlook; expects to be cash flow breakeven by 2024 end
  • It's JPM time! Which medtechs are expected to issue updates this week?
  • Akoya Biosciences GAAP EPS of -$0.26 beats by $0.10, revenue of $25.2M beats by $0.66M
  • Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant
  • Akoya Biosciences GAAP EPS of -$0.51 misses by $0.05, revenue of $23.52M beats by $1.08M
  • Akoya Biosciences director buys $1.02M in common stock
  • Akoya prices $44M offering; terminates chief medical officer, HR head
  • Akoya Biosciences announces common stock offering, no amount given
  • Akoya Biosciences GAAP EPS of -$0.49 in-line, revenue of $21.4M beats by $1.08M
  • Akoya Biosciences names Johnny Ek CFO as Driscoll retires
  • Akoya Biosciences GAAP EPS of -$0.50 misses by $0.06, revenue of $21.22M beats by $0.76M
  • Akoya guides Q4 and FY revenue above consensus
  • Akoya Biosciences GAAP EPS of -$0.47 misses by $0.04, revenue of $18.9M beats by $1.24M
  • Akoya Biosciences GAAP EPS of -$0.47 misses by $0.10, revenue of $17.9M beats by $0.97M
  • Akoya to co-develop Acrivon Therapeutics' companion diagnostic OncoSignature test
  • Akoya Biosciences GAAP EPS of -$0.44 misses by $0.05, revenue of $16.89M beats by $1.96M
  • Akoya Biosciences GAAP EPS of -$0.47 misses by $0.17, revenue of $16.2M beats by $0.15M
  • Akoya Biosciences launches spatial biology system PhenoCycler-Fusion
  • Akoya Biosciences reports Q4 ahead of analysts consensus; FY21 guidance trails consensus

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 -0.16 / - 9.95M / - Beat!
November 8, 2021 -0.3126 / -0.2601 13.48M / 13.06M Beat!
August 11, 2021 -0.17 / - 8.56M / - Beat!
August 10, 2021 -0.218 / -0.2312 13.07M / 12.59M Beat!
May 18, 2021 -3.54 / -0.1675 12.2M / 12.03M Beat!
March 3, 2021 -0.205 / - 12.8M / - Beat!
Date Price Open High Low Vol Change ER
Aug 7, 2023 6.32 6.43
6.7
6.08
143K -2.02%
Aug 4, 2023 6.45 6.57
6.66
6.43
97.4K -1.68%
Aug 3, 2023 6.56 6.59
6.88
6.5
117K -1.8%
Aug 2, 2023 6.68 6.65
6.74
6.5
59.3K -0.15%
Aug 1, 2023 6.69 6.9
6.9
6.66
70.8K -3.04%
 
Jul 31, 2023 6.9 6.88
7.06
6.75
105K 0.29%
Jul 28, 2023 6.88 6.85
6.9
6.63
42.6K 3.61%
Jul 27, 2023 6.64 7.01
7.02
6.59
58.5K -4.73%
Jul 26, 2023 6.97 6.72
7
6.68
64.4K 2.95%
Jul 25, 2023 6.77 6.78
6.96
6.66
114K -0.73%
Jul 24, 2023 6.82 7.11
7.3
6.81
77.4K -4.35%
Jul 21, 2023 7.13 7.07
7.19
6.88
93.9K 2%
Jul 20, 2023 6.99 7.42
7.47
6.86
95.2K -6.05%
Jul 19, 2023 7.44 7.09
7.55
7.09
171K 5.53%
Jul 18, 2023 7.05 6.95
7.16
6.9
115K 1.44%
Jul 17, 2023 6.95 6.96
7.28
6.91
106K -0.43%
Jul 14, 2023 6.98 6.8
7
6.74
118K 2.95%
Jul 13, 2023 6.78 7.49
7.59
6.72
181K -8.38%
Jul 12, 2023 7.4 7.04
7.53
7.03
138K 2.07%
Jul 11, 2023 7.25 7.13
7.3
7.02
107K 1.68%
Jul 10, 2023 7.13 6.75
7.18
6.63
139K 5.47%
Jul 7, 2023 6.76 6.48
6.8
6.48
91.3K 4%
Jul 6, 2023 6.5 6.79
6.79
6.43
132K -5.52%
Jul 5, 2023 6.88 7.26
7.26
6.84
131K -0.72%
Jul 3, 2023 6.93 7.33
7.68
6.82
58.8K -6.22%
Jun 30, 2023 7.39 7.35
7.68
7.05
208K 1.65%
Jun 29, 2023 7.27 6.97
7.3
6.89
235K 5.36%
Jun 28, 2023 6.9 6.68
7
6.5
192K 3.92%
Jun 27, 2023 6.64 6.78
6.78
6.38
219K -1.92%
Jun 26, 2023 6.77 6.96
7.03
6.68
220K -2.73%
Jun 23, 2023 6.96 6.98
7.02
6.84
615K -1.42%
Jun 22, 2023 7.06 7.09
7.22
6.91
187K -1.53%
Jun 21, 2023 7.17 7.54
7.6
7.14
261K -5.41%
Jun 20, 2023 7.58 8.26
8.31
7.47
380K -9%
Jun 16, 2023 8.33 8.5
8.8
7.94
567K -0.24%
Jun 15, 2023 8.35 7.82
8.59
7.35
812K 9.15%
Jun 14, 2023 7.65 7.79
8.23
7.5
2.0M 16.79%
Jun 13, 2023 6.55 6.04
6.7
5.98
823K 20.40%
Jun 12, 2023 5.44 5.38
5.55
5.15
337K 1.30%
Jun 9, 2023 5.37 5.36
5.6
5.15
643K 1.70%
Jun 8, 2023 5.28 4.83
5.7
4.28
2.2M -5.04%
Jun 7, 2023 5.56 5.77
5.85
5.54
323K -2.46%
Jun 6, 2023 5.7 5.44
5.99
5.37
236K 4.01%
Jun 5, 2023 5.48 5.78
6.03
5.43
606K -8.36%
Jun 2, 2023 5.98 5.78
6.08
5.64
69.9K 4.91%
Jun 1, 2023 5.7 5.63
5.73
5.36
91.1K 1.24%
May 31, 2023 5.63 5.74
5.78
5.47
81.4K -2.26%
May 30, 2023 5.76 5.56
5.93
5.45
70.6K 5.88%
May 26, 2023 5.44 5.82
5.82
5.27
100K -5.23%
May 25, 2023 5.74 6.11
6.28
5.68
162K -4.17%
May 24, 2023 5.99 5.77
6.12
5.76
105K 0%
May 23, 2023 5.99 6.41
6.57
5.94
95.6K -6.84%
May 22, 2023 6.43 5.91
6.55
5.89
79.1K 7.89%
May 19, 2023 5.96 6.02
6.29
5.83
106K 0%
May 18, 2023 5.96 6.07
6.07
5.82
57.7K -2.61%
May 17, 2023 6.12 6
6.14
5.8
51.5K 2.51%
May 16, 2023 5.97 5.79
6.24
5.6
124K 2.93%
May 15, 2023 5.8 5.76
5.99
5.69
216K 2.11%
May 12, 2023 5.68 6.35
6.35
5.62
120K -8.97%
May 11, 2023 6.24 6.68
6.8
6.2
73.0K 0%